Una Campbell

The triple reuptake inhibitor DOV216,303 exhibits limited antidepressant-like properties in the differential reinforcement of low-rate 72-second responding assay, likely due to dopamine reuptake inhibition

Fuat Balci, F. Balcı, B. Olivier, 2011, Journal of psychopharmacology.

In vivo phenotypic drug discovery: applying a behavioral assay to the discovery and optimization of novel antipsychotic agents

Liming Shao, Kerry L. Spear, N. Powell, 2016 .